The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.

Specialty contact lenses have a favorable benefit-cost ratio for patients with irregular cornea and ocular surface diseases.

Presbyopia correction and other eye care accessibility measures can radically enhance independence, confidence, and productivity.

A novel automated flipper has higher accuracy than a standard manual flipper in diagnosing inadequate accommodative facility in children.

A new drug application has been submitted for Brimochol™ PF (Tenpoint Therapeutics Ltd.) for the treatment of presbyopia.